3//SEC Filing
ELRAY RESOURCES, INC. 3
Accession 0001213900-24-113669
$ELRACIK 0001690080operating
Filed
Dec 30, 7:00 PM ET
Accepted
Dec 31, 7:55 AM ET
Size
6.2 KB
Accession
0001213900-24-113669
Insider Transaction Report
Form 3
ELRAY RESOURCES, INC.
10% Owner
Holdings
Series B Convertible Preferred Stock
From: 2024-12-27→ Common Stock (1,318,000 underlying)Common Stock Purchase Warrants
Exercise: $1.68From: 2024-12-27Exp: 2031-09-30→ Common Stock (3,000,000 underlying)
Footnotes (3)
- [F1]The conversion of the Series B Convertible Preferred Stock and exercise of the warrants was subject to shareholder approval, which shareholder approval was received on December 27, 2024.
- [F2]The Series B Convertible Preferred Stock has no expiration date. The Series B Convertible Preferred Stock is described in greater detail in the Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on October 3, 2024.
- [F3]Each of the 1,000,000 shares of Series B Convertible Preferred Stock is convertible into 1.318 shares of common stock.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001402371
Filing Metadata
- Form type
- 3
- Filed
- Dec 30, 7:00 PM ET
- Accepted
- Dec 31, 7:55 AM ET
- Size
- 6.2 KB